These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 39083738)

  • 1. Narcanazo: Community Activation of Antiracist Epidemiology.
    Oyola-Santiago T; Gelpí-Acosta C; Aponte-Meléndez Y; Cano M
    Am J Public Health; 2024 Jul; 114(S6):S463-S466. PubMed ID: 39083738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Drug Overdose Mortality for Island-Born and US-Born Puerto Ricans, 2013-2019.
    Cano M; Gelpí-Acosta C
    J Racial Ethn Health Disparities; 2022 Aug; 9(4):1403-1414. PubMed ID: 34081305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug overdose mortality among stateside Puerto Ricans: Evidence of a health disparity.
    Cano M; Gelpí-Acosta C
    Int J Drug Policy; 2021 Apr; 90():103079. PubMed ID: 33341699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity in Current Cigarette Smoking among Hispanic/Latino Heritage Groups in New York City, 2003-2016.
    Sisti JS; Jasek JP; Farley SM
    Ethn Dis; 2020; 30(1):97-108. PubMed ID: 31969789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inequities in naloxone administration among fatal overdose decedents by race and ethnicity in Pennsylvania, 2019-21.
    Takemoto E; Bolton A; Goetz CT
    Addiction; 2024 Aug; 119(8):1400-1409. PubMed ID: 38808397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Providing naloxone to substance users for secondary administration to reduce overdose mortality in New York City.
    Heller DI; Stancliff S
    Public Health Rep; 2007; 122(3):393-7. PubMed ID: 17518311
    [No Abstract]   [Full Text] [Related]  

  • 7. The Opioid Crisis and the Physician's Role in Contributing to its Resolution: Step One--Prevention of Overdoses.
    Wolfe S; Bouffard DL; Modesto-Lowe V
    Conn Med; 2016; 80(6):325-34. PubMed ID: 27509638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Rhode Island community responds to opioid overdose deaths.
    Bowman S; Engelman A; Koziol J; Mahoney L; Maxwell C; McKenzie M
    R I Med J (2013); 2014 Oct; 97(10):34-7. PubMed ID: 25271658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statewide Policy to Increase Provision of Take-Home Naloxone at Emergency Department Visits for Opioid Overdose, Rhode Island, 2018‒2019.
    Griffith J; Yorlets RR; Chambers LC; Davis CS; Wentz A; Beaudoin FL; Baird J; Samuels EA
    Am J Public Health; 2023 Apr; 113(4):372-377. PubMed ID: 36745856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naloxone use among overdose prevention trainees in New York City: A longitudinal cohort study.
    Siegler A; Huxley-Reicher Z; Maldjian L; Jordan R; Oliver C; Jakubowski A; Kunins HV
    Drug Alcohol Depend; 2017 Oct; 179():124-130. PubMed ID: 28772172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and implementation of an opioid overdose prevention and response program in Toronto, Ontario.
    Leece PN; Hopkins S; Marshall C; Orkin A; Gassanov MA; Shahin RM
    Can J Public Health; 2013 Apr; 104(3):e200-4. PubMed ID: 23823882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Feeling confident and equipped": Evaluating the acceptability and efficacy of an overdose response and naloxone administration intervention to service industry employees in New York City.
    Wolfson-Stofko B; Gwadz MV; Elliott L; Bennett AS; Curtis R
    Drug Alcohol Depend; 2018 Nov; 192():362-370. PubMed ID: 30287108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioids and deaths.
    Rich JD; Green TC; McKenzie MS
    N Engl J Med; 2011 Feb; 364(7):686. PubMed ID: 21323559
    [No Abstract]   [Full Text] [Related]  

  • 14. Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic.
    Irvine MA; Kuo M; Buxton JA; Balshaw R; Otterstatter M; Macdougall L; Milloy MJ; Bharmal A; Henry B; Tyndall M; Coombs D; Gilbert M
    Addiction; 2019 Sep; 114(9):1602-1613. PubMed ID: 31166621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naloxone protection, social support, network characteristics, and overdose experiences among a cohort of people who use illicit opioids in New York City.
    Bennett AS; Scheidell J; Bowles JM; Khan M; Roth A; Hoff L; Marini C; Elliott L
    Harm Reduct J; 2022 Mar; 19(1):20. PubMed ID: 35246165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DOH issues emergency regulations on expanding use of Narcan to prevent opioid overdose deaths.
    R I Med J (2013); 2014 Apr; 97(4):49. PubMed ID: 24960911
    [No Abstract]   [Full Text] [Related]  

  • 17. High risk and little knowledge: overdose experiences and knowledge among young adult nonmedical prescription opioid users.
    Frank D; Mateu-Gelabert P; Guarino H; Bennett A; Wendel T; Jessell L; Teper A
    Int J Drug Policy; 2015 Jan; 26(1):84-91. PubMed ID: 25151334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial/ethnic disparities in opioid overdose prevention: comparison of the naloxone care cascade in White, Latinx, and Black people who use opioids in New York City.
    Khan MR; Hoff L; Elliott L; Scheidell JD; Pamplin JR; Townsend TN; Irvine NM; Bennett AS
    Harm Reduct J; 2023 Feb; 20(1):24. PubMed ID: 36841763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of community opioid overdose prevention and naloxone distribution programs.
    Clark AK; Wilder CM; Winstanley EL
    J Addict Med; 2014; 8(3):153-63. PubMed ID: 24874759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "That's why we're speaking up today": exploring barriers to overdose fatality prevention in Indianapolis' Black community with semi-structured interviews.
    Seo DC; Satterfield N; Alba-Lopez L; Lee SH; Crabtree C; Cochran N
    Harm Reduct J; 2023 Oct; 20(1):159. PubMed ID: 37891632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.